Psyence Biomedical to acquire drug developer Clairvoyant Source: Seekingalpha
Browsing: drug
Stifel starts ORIC at purchase, cites prostate cancer drug candidate Source: Seekingalpha
Cigna to offer biosimilar to J&J’s arthritis drug Stelara at $0 out-of-pocket Source: Seekingalpha
lcodacci Genetic Leap, an organization targeted on AI-driven drug discovery, introduced Thursday a analysis collaboration price as much as $409M with Eli Lilly (NYSE:LLY) to develop…
Lisata jumps on FDA orphan drug status for liver cancer drug Source: Seekingalpha
Ascendis raised to outperform by Oppenheimer ahead of drug launch Source: Seekingalpha
Alnylam falls after full data for heart drug that can rival Pfizer’s Source: Seekingalpha
HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China Source: Seekingalpha
Novo highlights heart benefits of weight loss drug with new analysis Source: Seekingalpha
NuCana plunges after trial setback for cancer drug Source: Seekingalpha